Global health

Metabolica Health Completes Amalgamation with Big Fish and Announces Non-Brokered Private Placement

Retrieved on: 
Monday, February 26, 2024

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Metabolica Health Inc. ("Metabolica" or the "Company") a pioneering biotechnology firm at the forefront of diabetes and obesity treatment research, is pleased to announce the completion of its amalgamation (the "Amalgamation Agreement") with Big Fish Acquisition Corp. ("Big Fish"), effective on January 1, 2024, with the resulting amalgamated company, named Metabolica Health Inc. ("Metabolica Health"), continuing the business of Metabolica.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Metabolica Health Inc. ("Metabolica" or the "Company") a pioneering biotechnology firm at the forefront of diabetes and obesity treatment research, is pleased to announce the completion of its amalgamation (the "Amalgamation Agreement") with Big Fish Acquisition Corp. ("Big Fish"), effective on January 1, 2024, with the resulting amalgamated company, named Metabolica Health Inc. ("Metabolica Health"), continuing the business of Metabolica.
  • Pursuant to the terms of the Amalgamation Agreement dated October 30, 2023, Big Fish amalgamated with Metabolica to form Metabolica Health, and the issued shares of each of Metabolica and Big Fish were exchanged for shares of Metabolica Health or otherwise dealt with as follows: (a) each Class A Common share of Metabolica was exchanged for 22.213 common shares of Metabolica Health; and (b) each common share of Big Fish was exchanged for one-half of one common share of Metabolica Health.
  • Following the successful amalgamation transaction (the "Transaction"), Metabolica Health is pleased to announce that it is arranging a non-brokered private placement (the "Offering") of up to 2,500,000 Units, at a price of $0.40 per Unit, for gross proceeds of up to $1,000,000.
  • Furthermore, Metabolica Health is announcing the appointment of Mr. Scott Jardin, CPA, CGA, as the company's Chief Financial Officer.

HealthSprinter Announces Aim to Improve Health of One Billion People by 2028

Retrieved on: 
Thursday, February 22, 2024

San Francisco, California--(Newsfile Corp. - February 22, 2024) - HealthSprinter announces its aim to improve the health of one billion people by 2028.

Key Points: 
  • San Francisco, California--(Newsfile Corp. - February 22, 2024) - HealthSprinter announces its aim to improve the health of one billion people by 2028.
  • As a leading marketing firm dedicated to empowering health and wellness businesses, HealthSprinter has emerged as a global healthcare leader.
  • With a goal of improving the health of one billion people by 2028, the agency's ambitious vision reflects its unwavering commitment to global health improvement.
  • Founded in 2010 amidst a global health crisis, HealthSprinter is driven by the core belief that empowering health and wellness businesses can significantly improve health outcomes worldwide.

TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures

Retrieved on: 
Wednesday, February 28, 2024

MUMBAI, INDIA, Feb 28, 2024 - (ACN Newswire) - In a significant stride towards enhancing global health security and pandemic preparedness, TechInvention Lifecare Pvt.

Key Points: 
  • MUMBAI, INDIA, Feb 28, 2024 - (ACN Newswire) - In a significant stride towards enhancing global health security and pandemic preparedness, TechInvention Lifecare Pvt.
  • Ltd. is proud to announce the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with an investment of approx.
  • The centre is strategically located close to the upcoming international airport in Navi Mumbai, India.
  • GCMC has been acknowledged for its global significance at the 2nd World Local Production Forum in The Hague on 6-8 November 2023, organized by the WHO.

Aledade Appoints National Equity Expert to Board of Directors

Retrieved on: 
Monday, March 11, 2024

Bethesda, MD, March 11, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, has named a highly regarded diversity, equity and inclusion expert to its Board of Directors.

Key Points: 
  • Bethesda, MD, March 11, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, has named a highly regarded diversity, equity and inclusion expert to its Board of Directors.
  • Joyce A. Sackey , M.D., FACP, Chief Equity, Diversity and Inclusion Officer and Associate Dean at Stanford Medicine, is the newest member of Aledade’s Board of Directors.
  • “We are grateful to have Dr. Sackey join our board and share her expertise with us,” said Farzad Mostashari, M.D., co-founder and CEO of Aledade.
  • “At Aledade, we are deeply committed to advancing equity and inclusion as part of our mission and core values.

Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label

Retrieved on: 
Monday, March 11, 2024

This significant advancement supports the Company’s submission for an additional EPA label.

Key Points: 
  • This significant advancement supports the Company’s submission for an additional EPA label.
  • Foot-and-mouth disease (FMD) represents a critical global threat, being an extremely contagious disease affecting a wide range of cloven-hoofed animals including cows, pigs, sheep, goats, and deer.
  • TOMI’s recent study has proven SteraMist iHP technology to eliminate infectious FMDV from both porous (concrete) and non-porous (stainless steel) surfaces in the presence of organic soil load.
  • Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.

WTA Foundation and Gates Foundation launch new campaign—Women Change the Game—to urge action on women’s health and nutrition

Retrieved on: 
Friday, March 8, 2024

A key component of the campaign is the first-of-its-kind WTA Foundation Global Women’s Health Fund.

Key Points: 
  • A key component of the campaign is the first-of-its-kind WTA Foundation Global Women’s Health Fund.
  • “It is unacceptable that so many women and girls don’t have access to adequate nutrition and basic care,” said Melinda French Gates, co-chair of the Bill & Melinda Gates Foundation.
  • “The WTA Foundation was founded on the idea of equal opportunity, and that’s exactly what Women Change the Game is about.
  • For more information about Women Change the Game and the WTA Foundation’s Global Women’s Health Fund, visit www.womenchangethegame.com .

Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives

Retrieved on: 
Tuesday, March 5, 2024

These efforts underscore Mushrooms Inc.'s commitment to innovation, sustainability, and the advancement of global health.

Key Points: 
  • These efforts underscore Mushrooms Inc.'s commitment to innovation, sustainability, and the advancement of global health.
  • Mushrooms Inc. proudly introduces LONGEVITY and SPORT+, health supplements designed to harness the power of potent mushrooms and other proven ingredients for specific health and wellness goals.
  • These initiatives are part of Mushrooms Inc.'s broader strategy to address pressing health challenges through innovative, sustainable solutions.
  • For more information about our products, initiatives, and the potential German collaboration, please visit Mushrooms Inc.

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

Retrieved on: 
Tuesday, March 5, 2024

The Group’s CEO Dr. Philippe Wolgen also unveiled what is next for the most exciting biopharmaceutical firm in the field of photomedicine today.

Key Points: 
  • The Group’s CEO Dr. Philippe Wolgen also unveiled what is next for the most exciting biopharmaceutical firm in the field of photomedicine today.
  • Philanthropy is central to the work of Lady Gaga and Michael Polansky, Sean Parker and Alexandra Parker.
  • At the event in Malibu, CLINUVEL announced the Photomedicine Foundation, which will count Mr Polansky as a trustee.
  • CLINUVEL is grateful to have their support as we translate our pharmaceutical technology into PhotoCosmetics and give back to underserved communities.

Aspetar Attains ACGME International Accreditation

Retrieved on: 
Tuesday, February 27, 2024

Chicago, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ACGME International (ACGME-I) is proud to announce that Aspetar Orthopaedic and Sports Medicine Hospital in Doha, Qatar has been granted ACGME-I Initial Accreditation as a Sponsoring Institution.

Key Points: 
  • Chicago, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ACGME International (ACGME-I) is proud to announce that Aspetar Orthopaedic and Sports Medicine Hospital in Doha, Qatar has been granted ACGME-I Initial Accreditation as a Sponsoring Institution.
  • Aspetar is also one of 11 International Olympic Committee Research Centres.
  • “This accreditation underscores our dedication to equipping our staff with unparalleled education and expertise,” said Aspetar Chief Executive Officer Dr. Abdulaziz Al Kuwari.
  • ACGME International (ACGME-I) is an independent 501(c)(3) organization currently providing accreditation services to 200 graduate medical education programs in 23 institutions across 12 countries.

Wolters Kluwer experts explore Clinical GenAI and analytics solutions at HIMSS24

Retrieved on: 
Tuesday, March 5, 2024

Experts from Wolters Kluwer Health will be at HIMSS24 leading discussions on how advanced, integrated healthcare innovations are helping healthcare organizations deliver the best patient care around the world.

Key Points: 
  • Experts from Wolters Kluwer Health will be at HIMSS24 leading discussions on how advanced, integrated healthcare innovations are helping healthcare organizations deliver the best patient care around the world.
  • Visitors to booth #2927 will see demonstrations of how Wolters Kluwer Health is helping healthcare organizations drive better outcomes in healthcare through market leading clinical decision support, patient engagement, and drug referential solutions.
  • Learn how UpToDate’s approach to Clinical GenAI prioritizes quality, safety, and transparency with AI Labs.
  • Clinical GenAI can help improve and streamline clinical decision making at the point of care, reduce clinician burnout, and support healthcare organizations to help them deliver better patient outcomes and quality performance.